PBM for AMD now in NZ
Photobiomodulation (or LLLT) for AMD is now available in New Zealand
Lesley Springall3 min read
Ophthalmology Comment
Adjusting eyelid position brings dry eye relief
Dry eye disease (DED) is multifactorial in origin and, while intrinsic ocular surface pathology often garners the most attention, mechanical contributors, particularly those related to eyelid position and function, are sometimes underrecognised. In clinical oculoplastics practice, eyelid malposition
Dr Ayyad Khan, Dr Elin Bohman and Professor Tor Utheim4 min read
Drug therapy review for meibomian gland dysfunction
Dry, gritty, burning eyes? The most common culprit is meibomian gland dysfunction (MGD). These tiny glands, nestled within our eyelids, should secrete a lubricous oily substance termed meibum, which p
Jordan Cooper, Catherine Jennings and Dr Kalika Bandamwar7 min read
Radio host recalls how an optometrist saved her life
Dani Fennessy on her sight- and life-saving journey with IIH
Susie Hill3 min read
Ops, drops and diagnostics at the 2025 GNZ Symposium
Hosted at a new venue, the Maritime Room, the 9th Glaucoma New Zealand (GNZ) Symposium delivered an excellent programme with loads of great tips and content. The audience of ophthalmologists, optometr
Claire McDonald6 min read
Sharing dry eye knowledge in India
Ensuring evidence-based best practice reaches patients, both locally and globally, is at the heart of what we do as clinical educators. At the 2024 Tear Film & Ocular Surface Society (TFOS) conference in Venice, a chance meeting between then BCLA president Sarah Farrant, Indian ophthalmologist A
Dr Ally Xue and Sarah Farrant5 min read
Resolution of recurrent chalazion using LLLT
Recurrent chalazia present a challenge in clinical practice. Photobiomodulation is a novel approach to management, which, as described in this patient case, can offer encouraging results. A 42-year-
Catherine Wong and Sang Hoo Lee3 min read
TFOS - past, present and future
For me, it all began with a moongate. While a graduate student at Dartmouth Medical School (Hanover, US) in the mid-1970s, one of my mentors, the internationally renowned corticosteroid endocrinologist, the late Emeritus Professor Allan Munck, organised an exclusive meeting of approximately 25 stero
A/Prof David Sullivan6 min read
Dry eye research from laboratory to practice
It really is a momentous occasion when one of the Tear Film and Ocular Surface Society’s (TFOS’) global consensus reports is published: a culmination of years of work for many people, as they translat
Professor Jennifer Craig7 min read
Dry eye research review 2025
Identification of microplastics in human tear fluid and meibum: Implications for dry eye disease pathogenesis Jingyi Wang et al J Hazard Mater. 2025 Feb;489:137635 Review: This cross-sectional, la
Ally Xue5 min read
TFOS DEWS III: Advancing the understanding and management of dry eye disease
The 2007 Tear Film & Ocular Surface Society Dry Eye Workshop (TFOS DEWS)1 marked a major milestone in standardising the understanding and management of dry eye disease (DED). A decade later, TFOS DEWS II (2017)2 expanded on this foundation, supported by widespread global research. Now, TFOS DEWS
Professor Jennifer Craig and Jordan Cooper10 min read
APSPOS 2025 inspiring collaboration
The third congress of the Asia-Pacific Strabismus and Paediatric Ophthalmology Society (APSPOS) was held in Brisbane from 29 June to 1 July. The theme, ‘Inspiring collaboration’, was clear from the start as it was held in conjunction with annual meetings of the Australian and New Zealand Strabismus
Dr Samantha Simkin7 min read